COMMENTS TO AUTHORS
This is a brief review of the involvement of Insulin Receptor Substrates (IRS) in cognitive impairment and Alzheimer's disease. While the topic is indeed both interesting and novel, this review manuscript needs to be restructured in order to be more presentable. Specifically, lines of evidence and their application should be presented in a uniform manner, i.e. data applicable to directly to humans or ex vivo studies should be presented separately from mouse models and basic science evidence in general.
Furthermore, it feels that more studies should be included while exploring this subject, especially when aiming to provide a summary of such a complex pathway. Insulin signaling is a very hot topic in e.g. idiopathic parkinson's disease and IGF1 itself is a therapeutic target; while not directly linked to AD or MCI, the comparisons cannot be ignored when exploring complex topics such as neuroprotection.
